Answers are grounded in this paper and cite their sources.
Purpose of review In this review, the current literature available to patients and providers on the multidisciplinary management of nonmetastatic locally advanced prostate cancer (T3-T4N0M0) was reviewed. Topics include the definition of the disease, the distinction between nonmetastatic locally advanced prostate cancer and locally advanced prostate cancer defined by the EUA and high-risk prostate cancer by NCCN and AUA guidelines, the role of radiation therapy in addition to androgen deprivation therapy, the current role of surgery and lypmh node dissectionthe difference between adjuvant vs. salvage treatment for such patients. Although there are multiple curative treatment approaches for locally advanced prostate cancer, no consensus regarding the optimal treatment option exists. Recent findings Historically, the use of androgen deprivation therapy (ADT) and external beam radiotherapy (EBRT) has been used in locally advanced prostate cancer 1 . More recently, retrospective observational data showed equivalent results for patients undergoing primary radical prostatectomy with radiation therapy reserved as an adjuvant or salvage treatment as needed, and better outcomes were seen after advances in patient selection which include improvements in staging imaging with mpMRI and PSMA PET 2,3 . Adjuvant radiation based on adverse features on pathology has also come into dispute, with early salvage showing non-inferior oncological outcomes and a more favorable toxicity profile. Summary Until high-level evidence evaluating surgery versus EBRT plus androgen deprivation therapy (ADT) for locally advanced disease is available as a result of the ongoing trial SPCG-15, options for patients with locally advanced prostate cancer include local radiotherapy in combination with androgen deprivation therapy (level I evidence) and radical prostatectomy with pelvic lymph node dissection for well-selected patients. Early salvage radiotherapy is non-inferior to adjuvant radiation.
No takes yet. Share an insight, caveat, or question.
Bigarella et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: